Invention Grant
- Patent Title: Targeting of glycoprotein therapeutics
-
Application No.: US16048176Application Date: 2018-07-27
-
Publication No.: US10792342B2Publication Date: 2020-10-06
- Inventor: James Stefano
- Applicant: Genzyme Corporation
- Applicant Address: US MA Cambridge
- Assignee: Genzyme Corporation
- Current Assignee: Genzyme Corporation
- Current Assignee Address: US MA Cambridge
- Agency: Morrison & Foerster LLP
- Main IPC: A61K38/47
- IPC: A61K38/47 ; A61K47/60 ; A61K47/61 ; A61K47/64 ; C12N9/40 ; C12N9/96 ; A61P43/00 ; A61P3/00

Abstract:
Methods of making ligand-decorated polymer conjugates of therapeutic glycoproteins are described. Improved targeting of glycoproteins to specific tissues is achieved by masking the natural carbohydrate and other surface determinants with high molecular weight polymers, such as, e.g., PEG, polysialic acid, etc., which in turn are decorated with target-specific ligands. In some embodiments, acid-labile linkages in such conjugates or rapidly degradable masking groups allow for the intracellular release of the polymer from the glycoprotein, for example, under conditions found in lysosomes.
Public/Granted literature
- US20190054154A1 TARGETING OF GLYCOPROTEIN THERAPEUTICS Public/Granted day:2019-02-21
Information query
IPC分类: